Skip to main content
TipRanks
Go Ultimate75% OFF

Apple Tree Partners , L.P. Insider Profile

4 Followers

Apple Tree Partners , L.P., Ten Percent Owner at Stoke Therapeutics, holds 0.00 shares in Stoke Therapeutics (Ticker: STOK), holds 0.00 shares in Akero Therapeutics (Ticker: AKRO), holds 125.00K shares in Eledon Pharmaceuticals (Ticker: ELDN).

Apple Tree Partners , L.P.'s Trading History

AKRO
Akero Therapeutics
Jun 30, 2021―Uninformative Sell―$0.00
STOK
Stoke Therapeutics
Jun 30, 2021Ten Percent OwnerUninformative Sell―$0.00
ELDN
Eledon Pharmaceuticals
Sep 24, 2014Director, Ten Percent OwnerInformative Buy―$246.25K

You May Also Like

Apple Tree Partners , L.P. insider profile FAQ

What is the percentage of profitable transactions made by Apple Tree Partners , L.P.?
The percentage of profitable transactions made by Apple Tree Partners , L.P. is 20%.
What is the average return per transaction made by Apple Tree Partners , L.P.?
The average return per transaction made by Apple Tree Partners , L.P. is -14.40%.
What stocks does Apple Tree Partners , L.P. hold?
Apple Tree Partners , L.P. holds: STOK, ELDN, AKRO stocks.
What was Apple Tree Partners , L.P.'s most profitable transaction?
Apple Tree Partners , L.P.’s most profitable transaction was an Informative Buy of AKRO stock on June 25, 2019. The return on the trade was 39.40%.
What is Apple Tree Partners , L.P.'s role in Stoke Therapeutics?
Apple Tree Partners , L.P.'s role in Stoke Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.